Mounjaro (tirzepatide) is an injectable prescription medicine used to improve blood sugar control in adults with type 2 diabetes.
Mounjaro (tirzepatide) is a first-in-class medicine indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Manufactured by Eli Lilly and Company, it works as a dual GIP and GLP-1 receptor agonist to regulate blood sugar levels.
Mounjaro is administered once weekly via a single-dose pre-filled pen injected subcutaneously. The medication mimics natural hormones to help the body release insulin when blood sugar is high and reduce the amount of sugar the liver produces.
Latest manuals from manuals+ curated for this brand.
Common questions about manuals, registration, and support for this brand.
Store your pen in the refrigerator between 36°F to 46°F (2°C to 8°C). You may store the pen at room temperature up to 86°F (30°C) for up to 21 days if needed. Do not freeze the pen.
You can inject the medicine in your stomach (abdomen) or thigh. If injecting in the upper arm, another person should administer the injection. Rotate your injection site each week.
Yes, air bubbles in the pen are normal and do not affect its functionality.
No, the pen does not need to be warmed to room temperature before use, though some patients may find it more comfortable.
You will hear a second loud click, and the grey plunger will be visible. Hold the pen against your skin until these indicators occur.